Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. (2015)

First Author: Kawagashira Y
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2014.11.006

PubMed Identifier: 25467141

Publication URI: http://europepmc.org/abstract/MED/25467141

Type: Journal Article/Review

Volume: 348

Parent Publication: Journal of the neurological sciences

Issue: 1-2

ISSN: 0022-510X